Relación entre tipo y cantidad de carbohidratos dietarios con el perfil lipídico y ApoB100 en adultos

Relación entre tipo y cantidad de carbohidratos dietarios con el perfil lipídico y ApoB100 en adultos

Relationship between the type and quantity of dietary carbohydrates, and the lipid profile and ApoB100 in adults. Objective.To establish if there is any relationship between the type and amount of dietary carbohydrates commonly consumed and the plasmaticlevels of lipids, lipoproteins and apolipoprot...

Full description

Bibliographic Details
Main Authors:	Martha Guerra, Myriam Ojeda-Arredondo, Martha Alvarado, Juliana Escobar
Format:	Article
Language:	English
Published:	Pontificia Universidad Javeriana 2010-08-01
Series:	Universitas Scientiarum
Subjects:	apolipoprotein B100 carbohydrates plasmatic lipids lipoproteins
Online Access:	http://revistas.javeriana.edu.co/index.php/scientarium/article/view/1369/832

Similar Items

Identification of autoantibodies in human plasma recognizing an apoB-100 LDL receptor binding site peptide
by: Gunilla Nordin Fredrikson, et al.
Published: (2006-09-01)

Metabolism of apoB lipoproteins of intestinal and hepatic origin during constant feeding of small amounts of fat
by: Chunyu Zheng, et al.
Published: (2006-08-01)

Epigallocatechin gallate increases the formation of cytosolic lipid droplets and decreases the secretion of apoB-100 VLDL
by: Lu Li, et al.
Published: (2006-01-01)

Oxidative events cause degradation of apoB-100 but not of apo[a] and facilitate enzymatic cleavage of both proteins
by: Celina Edelstein, et al.
Published: (2001-10-01)

Abnormal in vivo metabolism of apoB-containing lipoproteins in human apoE deficiency
by: Katsunori Ikewaki, et al.
Published: (2004-07-01)

Ubiquitination regulates the assembly of VLDL in HepG2 cells and is the committing step of the apoB-100 ERAD pathway[S]
by: Eric A. Fisher, et al.
Published: (2011-06-01)

ApoA-IV modulates the secretory trafficking of apoB and the size of triglyceride-rich lipoproteins
by: Richard B. Weinberg, et al.
Published: (2012-04-01)

2D-NMR reveals different populations of exposed lysine residues in the apoB-100 protein of electronegative and electropositive fractions of LDL particles[S]
by: Francisco J. Blanco, et al.
Published: (2010-06-01)

Antisense oligonucleotide reduction of apoB-ameliorated atherosclerosis in LDL receptor-deficient mice[S]
by: Adam E. Mullick, et al.
Published: (2011-05-01)

ApoB-containing lipoproteins in apoE-deficient mice are not metabolized by the class B scavenger receptor BI
by: Nancy R. Webb, et al.
Published: (2004-02-01)

Secretion of apoB- and apoA-I-containing lipoproteins by chick kidney
by: Patrizia Tarugi, et al.
Published: (1998-04-01)

Immunochemical evidence that human apoB differs when expressed in rodent versus human cells
by: Xingyu Wang, et al.
Published: (2003-03-01)

ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan
by: Katherine Olin-Lewis, et al.
Published: (2002-11-01)

The molecular mechanisms underlying the reduction of LDL apoB-100 by ezetimibe plus simvastatins⃞
by: Dawn E. Telford, et al.
Published: (2007-03-01)

Utility of non-HDL-C and apoB targets in the context of new more aggressive lipid guidelines
by: Renato Quispe, et al.
Published: (2021-09-01)

Increased production of VLDL apoB-100 in subjects with familial hypercholesterolemia carrying the same null LDL receptor gene mutation
by: André J. Tremblay, et al.
Published: (2004-05-01)

Overexpression of SR-BI by adenoviral vector promotes clearance of apoA-I, but not apoB, in human apoB transgenic mice
by: Nancy R. Webb, et al.
Published: (2002-09-01)

Apolipoprotein[a] secretion from hepatoma cells is regulated in a size-dependent manner by alterations in disulfide bond formation
by: Fatiha Nassir, et al.
Published: (2003-04-01)

ApoB-48 and apoB-100 differentially influence the expression of type-III hyperlipoproteinemia in APOE*2 mice
by: Myron E. Hinsdale, et al.
Published: (2002-09-01)

Overexpression ofapoC-III produces lesser hypertriglyceridemia in apoB-48-only gene-targeted micethan in apoB-100-only mice
by: Karin Conde-Knape, et al.
Published: (2004-12-01)

Immuno-electron cryo-microscopy imaging reveals a looped topology of apoB at the surface of human LDL[S]
by: Yuhang Liu, et al.
Published: (2011-06-01)

A fish oil diet produces different degrees of suppression of apoB and triglyceride secretion in human apoB transgenic mouse strains
by: Carol Ko, et al.
Published: (2003-10-01)

Dimyristoylphosphotidylcholine induces conformational changes in apoB that lowers lipoprotein(a)
by: Yan-Ting Wang, et al.
Published: (2009-05-01)

Regulation of macrophage apoE secretion and sterol efflux by the LDL receptor
by: Danijela Lucic, et al.
Published: (2007-02-01)

Microsomal triglyceride transfer protein is essential for hepatic secretion of apoB-100 and apoB-48 but not triglyceride
by: To Yuen Hui, et al.
Published: (2002-05-01)

PPARα and PPARγ activators suppress the monocyte-macrophage apoB-48 receptor1
by: Go Haraguchi, et al.
Published: (2003-06-01)

Biphasic Production of Anti-ApoB100 Autoantibodies in Obese Humans and Mice
by: Moon Kyung Choe, et al.
Published: (2021-04-01)

Hypertensive Disorders of Pregnancy: Assessing the Significance of Lp(a) and ApoB Concentrations in a Romanian Cohort
by: Simona-Alina Abu-Awwad, et al.
Published: (2023-09-01)

Discordantly normal ApoB relative to elevated LDL-C in persons with metabolic disorders: A marker of atherogenic heterogeneity
by: Alexander C. Razavi, et al.
Published: (2021-09-01)

Metabolism of lipoproteins containing apolipoprotein B in hepatic lipase-deficient mice
by: Shiqiang Qiu, et al.
Published: (1998-08-01)

Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractionss⃞
by: Zheng Chunyu, et al.
Published: (2007-05-01)

ApoE genotype affects allele-specific apo[a] levels for large apo[a] sizes in African Americans: the Harlem-Basset Studys⃞
by: Erdembileg Anuurad, et al.
Published: (2007-03-01)

Characterization of apoM in normal and genetically modified mice
by: Kirsten Faber, et al.
Published: (2004-07-01)

Evaluación de las concentraciones de lípidos y apoproteínas A-I y B-100 en un grupo de escolares de cinco departamentos del centro-oriente de Colombia
by: Elpidia Poveda, et al.
Published: (2007-09-01)

ApoE knockout and knockin mice: the history of their contribution to the understanding of atherogenesis
by: Godfrey S. Getz, et al.
Published: (2016-05-01)

Short-term overexpression of DGAT1 or DGAT2 increases hepatic triglyceride but not VLDL triglyceride or apoB production
by: John S. Millar, et al.
Published: (2006-10-01)

Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis
by: Eftaxia-Konstantina Valanti, et al.
Published: (2018-10-01)

Sources and properties of triglyceride-rich lipoproteins containing apoB-48 and apoB-100 in postprandial blood plasma of patients with primary combined hyperlipidemia
by: J. Kovar, et al.
Published: (2002-07-01)

Effects of atorvastatin versus fenofibrate on apoB-100 and apoA-I kinetics in mixed hyperlipidemia
by: Stefan Bilz, et al.
Published: (2004-01-01)

APOE in the normal brain
by: Sarah A. Flowers, et al.
Published: (2020-03-01)